CAMP4 Therapeutics (Nasdaq: CAMP) raises $50.1M in second private placement closing
CAMP4 Therapeutics has completed the second closing of its $100 million private placement, raising approximately $50.1 million in gross proceeds. The company issued common stock and pre-funded warrants to institutional and accredited investors, as well as to certain directors and employees. The funds will …